The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment: (ASCP Corner)
Open accessAbstract
Article Abstract Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text. The relationship between bipolar disorder and attention-deficit/hyperactivity disorder (ADHD) has received considerable attention in psychiatric research. Elevated rates of bipolar disorder-ADHD comorbidity among youth and coaggregation within families raise questions as to whether co-occurring bipolar disorder and ADHD represent (1) a more severe subtype of bipolar disorder, (2) related disorders with a shared genetic predisposition, or (3) separate though frequently comorbid disorders. Regardless of etiology, co-occurrence of bipolar disorder and ADHD has been associated with adverse illness outcomes in both disorders, consistent with bipolar disorder-ADHD comorbidity being a marker for poorer prognosis and thus a more severe subtype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Distinguishing early‐onset mania or hypomania from other psychiatric disorders is important as there is a high level of symptomatic overlap for multiple conditions including but not limited to ADHD, oppositional defiant disorder (ODD), disruptive mood dysregulation disorder (DMDD), substance abuse, personality disorders and generalized anxiety disorder555, 570 (Table 22).”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [570]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515
Centers for Disease Control and Prevention (CDC)
Rovner, J. (2009) · Health Care Policy and Politics A to Z · doi:10.4135/9781452240121.n54 · Cited by 69
Flagged first, then by citations
Research works printed but not linked: 20
- [1]1. DelBello MP, Hanseman D, Adler CM, et al. Am J Psychiatry. 2007;164(4):582-590. d o i : 1 0 . 1 1 7 6 / a p p i . a j p . 1 6 4 . 4 . 5 8
- [2]2. P u b M e d 2. Arnold LE, Demeter C, Mount K, et al. Bipolar Disord. 2011;13(5-6):509-521. d o i : 1 0 . 1 1 1 1 / j . 1 3 9 9 -5 6 1 8 . 2 0 1 1 . 0 0 9
- [3]3. x P u b M e d 3. Merikangas KR, Akiskal HS, Angst J, et al. Arch Gen Psychiatry. 2007;64(5):543-552. d o i : 1 0 . 1 0 0 1 / a r c h . 6 4 . 5 . 5 4
- [4]4. P u b M e d 4. Leibenluft E, Rich BA. Annu Rev Clin Psychol. 2008;4(1):163-187. : 1
- [5]5. Kessler RC, Berglund P, Demler O, et al. Arch Gen Psychiatry. 2005;62(6):593-602. d o i : 1 0 . 1 0 0 1 / a r c . 6 2 . 6 . 5 9 3 P u b M e d 6. Gaub M, Carlson CL. J Am Acad Child Adolesc Psychiatry. 1997;36(8):1036-1045. d o i : 1 0 . 1 0 9 7 / 0 0 0 0 4 5 8 3 -1 9 9 7 0 8 0 0 0 -0 0 0 1
- [7]7. Tillman R, Geller B. Dev Psychopathol. 2006;18(4):1037-1053. d o i : 1 0 . 1 0 1 7 / S 0 9 5 4 5 7 9 4 0
- [9]9. Masi G, Perugi G, Toni C, et al. Bipolar Disord. 2006;8(4):373-381. d o i : 1 0 . 1 1 1 1 / j . 1 3 9 9 -5 6 1 8 . 2 0 0 6 . 0 0 3
- [10]10. x P u b M e d 9. Wozniak J, Biederman J, Kiely K, et al. J Am Acad Child Adolesc Psychiatry. 1995;34(7):867-876. d o i : 1 0 . 1 0 9 7 / 0 0 0 0 4 5 8 3 -1 9 9 5 0 7 0 0 0 -0 0 0 1
- [12]12. Biederman J, Faraone S, Mick E, et al. J Am Acad Child Adolesc Psychiatry. 1996;35(8):997-1008. d o i : 1 0 . 1 0 9 7 / 0 0 0 0 4 5 8 3 -1 9 9 6 0 8 0 0 0 -0 0 0 1
- [14]14. Wozniak J, Spencer T, Biederman J, et al. J Affect Disord. 2004;82(suppl 1): S59-S69. d o i : 1 0 . 1 0 1 6 / j . j a d . 2 0 0 4 . 0 5 . 0 1 3 P u b M e d 12. Singh MK, DelBello MP, Kowatch RA, et al. Bipolar Disord. 2006;8(6): 710-720. d o i : 1 0 . 1 1 1 1 / j . 1 3 9 9 -5 6 1 8 . 2 0 0 6 . 0 0 3 9
- [17]17. Stringaris A, Santosh P, Leibenluft E, et al. J Child Psychol Psychiatry. 2010;51(1):31-38. d o i : 1 0 . 1 1 1 1 / j . 1 4 6 9 -7 6 1 0 . 2 0 0 9 . 0 2 1 2
- [18]18. x P u b M e d 15. Merikangas KR, Cui L, Kattan G, et al. Arch Gen Psychiatry. 2012;69(9):943-951. d o i : 1 0 . 1 / a M e d
- [19]19. Faraone SV, Biederman J, Mennin D, et al. J Am Acad Child Adolesc Psychiatry. 1997;36(10):1378-1387, discussion 1387-1390. d o i : 1 0 . 1 0 9 7 / 0 0 0 0 4 5 8 3 -1 9 9 7 1 0 0 0 0 -0 0 0 2
- [21]21. Chang KD, Steiner H, Ketter TA. J Am Acad Child Adolesc Psychiatry. 2000;39(4):453-460. d o i : 1 0 . 1 0 9 7 / 0 0 0 0 4 5 8 3 -2 0 0 0 0 4 0 0 0 -0 0 0 1
- [22]22. P u b M e d 18. Faraone SV, Biederman J, Wozniak J. Am J Psychiatry. 2012;169(12):1256-1266. d o i : 1 0 . 1 1 7 6 / a p p i . a j p . 2 0 1 2 . 1 2 0 1 0 0 8
- [23]23. P u b M e d 19. Milberger S, Biederman J, Faraone SV, et al. Am J Psychiatry. 1995;152(12):1793-1799.
- [24]24. P u b M e d 20. Luckenbaugh DA, Findling RL, Leverich GS, et al. Bipolar Disord. 2009;11(4):441-451. d o i : 1 0 . 1 1 1 1 / j . 1 3 9 9 -5 6 1 8 . 2 0 0 9 . 0 0 6 8
- [25]25. x P u b M e d 21. Geller B, Zimerman B, Williams M, et al. J Child Adolesc Psychopharmacol. 2002;12(1):11-25. d o i : 1 0 . 1 0 8 9 / 1 0 4 4 5 4 6 0 2 5 2 9 4 3 5
- [27]27. Goldsmith M, Singh M, Chang K. Paediatr Drugs. 2011;13(4):225-243. d o i : 1 0 . 2 1 6 5 / 1 1 5 9 1 6 6 0 -0 0 0 0 0 0 0 0 0 -0 0 0
- [29]29. Pagano ME, Demeter CA, Faber JE, et al. Bipolar Disord. 2008;10(2):334-341. d o i : 1 0 . 1 1 1 1 / j . 1 3 9 9 -5 6 1 8 . 2 0 0 7 . 0 0 4
Cited by
Sorted by citations
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Soncin, S., Brien, D. C., Coe, B. C., Marin, A., & Munoz, D. P. (2016) · Behavioral Neuroscience · doi:10.1037/bne0000158 · Cited by 30
Attachment Styles and Psychopathology among Adolescent Children of Parents with Bipolar Disorder
Fettahoğlu, E. Ç. (2015) · Medical Science Monitor · doi:10.12659/msm.893372 · Cited by 15
“Additionally, some studies have reported the coexistence of ADHD and BD in children and adolescents [36].”
BackgroundPouchon, A., Nasserdine, R., Dondé, C., Bertrand, A., Polosan, M., & Bioulac, S. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2224920 · Cited by 12
“Additionally, there is a lot of symptoms overlap across a number of diseases, such as but not limited to ADHD, oppositional defiant disorder, disruptive mood dysregulation disorder (DMDD), substance abuse, personality disorders, and generalized anxiety disorder (GAD) [15,16].”
BackgroundLee, T. (2016) · Pediatric Annals · doi:10.3928/19382359-20160920-01 · Cited by 9
Metadata
- Authors
- Miller, S., Chang, K. D., & Ketter, T. A.
- Affiliations
- Stanford Medicine (US)
- VA Palo Alto Health Care System (US)
- Corresponding author
- Miller, Shefali
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2013-06-15
- Volume
- 74
- Issue
- 06
- Pages
- 628-629
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1488416685
- Cited by
- 11
- References
- 2
- Citations by year
- 2024: 1 · 2023: 1 · 2020: 1 · 2018: 1 · 2016: 3 · 2015: 1 · 2014: 3
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline
- Teva Pharmaceutical Industries
- Sunovion
- Agency for Healthcare Research and Quality
- Allergan
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- bipolar disorder, attention deficit hyperactivity disorder, comorbidities, children and adolescents, diagnosis, treatment, genetic susceptibility, prognosis, disease outcome
- MeSH terms
- Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Bipolar Disorder, Child, Diagnosis, Differential, Humans, Comorbidity, Disease Progression, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
